The Governing Board is composed of members from the 1+ Million Genomes (1+MG) signatory and observer countries. The Board is the final decision making body of the B1MG project and provides strategic guidance, with the support of the Scientific and Ethic Advisory Board and the National Mirror Groups.
The Board meets quarterly to be updated by the Coordination Office on the project progress. When feasible Board meeting are collocated with 1+MG signatories or 1+MG Working Group meetings.
The Board members can propose additional members (countries) at any time during the project. The Coordination Office will seek the approval of the Governing Board for any significant modifications to the project (e.g. change of WP plans, or reallocation of budget above €30k).
| Country |
Member |
|
Members from the 1+MG signatory countries
|
| Austria |
Robert Scharinger (Ministry of Health) |
| Bulgaria |
Zhasmina Balabanova (Bulgarian Alliance for Precision and Personalized Medicine) |
| Croatia |
Ingeborg Barisic (Children's University Hospital Zagreb, Department of Medical Genetics and Reproductive Health) |
| Cyprus |
Carolina Stylianou (Ministry of Health) |
| Czech Republic |
Sarka Pospisilova (Masaryk University) |
| Estonia |
Angela Ivask (Ministry of Social Affairs of Estonia) |
| Finland |
Tuula Helander (Ministry of Social Affairs and Health)
Markus Perola (Finnish Institute for Health and Welfare) |
| Germany |
Dagmar Friese (Federal Ministry of Health) |
| Greece |
Dimitris Thanos (Biomedical Research Foundation Academy of Athens) |
| Hungary |
Attila Patócs (National Institute of Oncology) |
| Italy |
Antonio Federici (Italian Ministry of Health) |
| Latvia |
Davids Fridmanis (Latvian Biomedical Research and Study Centre)
Annika Smilga (Deputy) (The Centre for Disease Prevention and Control of Latvia, Register’s Management unit) |
| Lithania |
Laima Ambrozaityte (Vilnius University Hospital Santaros Klinikos)
Anželika Balčiūnienė (Ministry of Health) |
| Luxembourg |
Thomas Dentzer (Ministry of Health) |
| Malta |
Nomination in progress. |
| Norway |
Grethe Foss (Norwegian Directorate of Health) |
| Portugal |
Astrid Vicente (Instituto Nacional de Saúde Doutor Ricardo Jorge, Ministry of Health)
Manuel Santos (University of Aveiro, Institute of Biomedicine, Medical Sciences Department) |
| Slovenia |
Borut Peterlin (Slovene Ministry of Health)
Brane Leskošek (University of Ljubljana; ELIXIR-SI) |
| Spain |
Gonzalo Arévalo (Deputy General Director for International Research Programmes and
Institutional Relations, ISCIII) |
| Sweden |
Sverker Lundin (Swedish Research Council)
Frida Lundmark (Swedish Innovation Agency) |
| The Netherlands |
Ruben Kok (DTL Director) |
| UK |
To be confirmed. |
| Members from non-signatory countries |
| Belgium |
Marc Van Den Bulcke (Sciensano) |
| France |
Bertrand Schwartz (Ministry of Higher Education, Research and Innovation) |
| Switzerland |
Adrien Lawrence (Dr Sc, Managing Director, Swiss Personalized Health Network SPHN) |
See also: